首页|血清外泌体SUMO1P3和MALAT1对三阴性乳腺癌患者术后复发转移的预测价值

血清外泌体SUMO1P3和MALAT1对三阴性乳腺癌患者术后复发转移的预测价值

扫码查看
目的 探讨血清外泌体小泛素样修饰子 1 伪基因 3(SUMO1P3)和肺腺癌转移相关转录本 1(MALAT1)对三阴性乳腺癌(TNBC)患者术后复发转移的预测价值.方法 选取 2016 年至 2020 年行手术切除的 224 例TNBC患者作为研究对象,根据随访期内复发及转移情况分为非复发转移组和复发转移组,收集两组患者的临床病历资料.采用实时荧光定量PCR(qPCR)检测术前血清外泌体SUMO1P3 和MALAT1 表达,绘制受试者工作特征(ROC)曲线评价SUMO1P3 和MALAT1 对TNBC术后复发转移的预测价值.采用多因素Logistic回归模型分析影响TNBC术后复发转移的因素.结果 共72 例患者出现复发或转移.224 例 TNBC 患者 SUMO1P3 和 MALAT1 相对表达量分别为 3.06±0.68 和 2.75±0.66,其中复发转移组SUMO1P3 和MALAT1 相对表达量为 3.44±0.67 和 3.46±0.80,均显著高于非复发转移组的 2.88±0.61 和 2.33±0.48(P<0.001).ROC曲线结果显示,血清外泌体SUMO1P3 和MALAT1 联合检测的曲线下面积(AUC)=0.842(95%CI:0.787~0.887),特异度为 0.790,灵敏度为 0.806,且两指标联合预测的效能优于SUMO1P3 和MALAT1 单独预测(P<0.05).多因素Logistic回归模型结果显示,SUMO1P3(OR=4.463,95%CI:2.125~9.372)和MALAT1(OR=9.103,95%CI:4.462~18.573)表达是影响TNBC术后复发转移的独立因素(P<0.05).结论 血清外泌体SUMO1P3 和MALAT1 与TNBC患者预后密切相关,两指标联合检测对TNBC术后复发或转移具有较高的预测价值.
The predictive value of serum exosome SUMO1P3 and MALAT1 for postoperative recurrence and metastasis in patients with triple-negative breast cancer
Objective To investigate the predictive value of serum exosome small ubiquitin-like modifier-1 pseudogene 3(SUMO1P3)and metastasis associated lung adenocarcinoma transcript 1(MALAT1)in postoperative recurrence and metastasis in patients with triple-negative breast cancer(TNBC).Methods A total of 224 patients with TNBC who underwent surgical resection from 2016 to 2020 were selected as the study subjects.According to the recurrence and metastasis during the follow-up period,they were divided into non-recurrence metastasis group and recurrence metastasis group.Clinical medical records of the two groups were collected.Real-time quantitative fluorescent PCR(qPCR)was used to detect the expression of serum exosomes SUMO1P3 and MALAT1 before surgery,and receiver operating characteristic(ROC)curve was drawn to evaluate the predictive value of SUMO1P3 and MALAT1 in postoperative recurrence and metastasis of TNBC.Multivariate Logistic regression model was used to analyze the factors affecting recurrence and metastasis after TNBC.Results A total of 72 patients had recurrence or metastasis.The relative expression levels of SUMO1P3 and MALAT1 in 224 TNBC patients were 3.06±0.68 and 2.75±0.66,respectively,among which the relative expression levels of SUMO1P3 and MALAT1 in the relapsed and metastatic group were 3.44±0.67 and 3.46±0.80,respectively.They were significantly higher than 2.88±0.61(P<0.001)and 2.33±0.48(P<0.001)in the non-recurrent metastasis group.ROC curve results showed that AUC of serum exosome SUMO1P3 and MALAT1 combined detection was 0.842(95%CI:0.787-0.887),the specificity was 0.790,the sensitivity was 0.806,and the combined prediction efficiency of the two indexes was better than that of SUMO1P3 and MALAT1 alone(P<0.05).Multivariate Logistic regression model showed that SUMO1P3(OR=4.463,95%CI:2.125-9.372)and MALAT1(OR=9.103,95%CI:4.462-18.573)expression was an independent factor affecting the recurrence and metastasis after TNBC(P<0.05).Conclusion Serum exosomes SUMO1P3 and MALAT1 are closely related to the prognosis of TNBC patients,and the combined detection of the two indicators has a high predictive value for postoperative recurrence or metastasis of TNBC.

Triple-negative breast cancer(TNBC)ExosomeSmall ubiquitin-like modifier-1 pseudogene 3(SUMO1P)Lung adenocarcinoma metastasis-related transcript 1(MALAT1)RecurrenceMetastasis

郭向阳、苗立峰、张国琛

展开 >

030013 太原 山西省肿瘤医院乳腺外科

三阴性乳腺癌 外泌体 小泛素样修饰子1伪基因3 肺腺癌转移相关转录本1 复发 转移

2024

临床肿瘤学杂志
解放军第八一医院

临床肿瘤学杂志

CSTPCD
影响因子:1.583
ISSN:1009-0460
年,卷(期):2024.29(6)
  • 4